Novocure announces that interim data from its Phase 2 STELLAR trial assessing Tumor Treating Fields plus standard chemo in patients with advance mesothelioma will be presented on Wednesday, December 7 at the 17th World Conference on Lung Cancer in Vienna, Austria.
